Funmilayo O. Adeshakin

Beijing, 100864, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

NY-ESO-1 facilitates anoikis resistance and tumor metastasis by hijacking deubiquitinase OTUB1 to stabilize PP1α.

NY-ESO-1 facilitates anoikis resistance and tumor metastasis by hijacking deubiquitinase OTUB1 to stabilize PP1α.

Journal: Cell death & disease
Published: January 25, 2025

Multifaceted roles of DLG3/SAP102 in neurophysiology, neurological disorders and tumorigenesis.

Multifaceted roles of DLG3/SAP102 in neurophysiology, neurological disorders and tumorigenesis.

Journal: Neuroscience
Published: September 06, 2024

CD317 maintains proteostasis and cell survival in response to proteasome inhibitors by targeting calnexin for RACK1-mediated autophagic degradation.

CD317 maintains proteostasis and cell survival in response to proteasome inhibitors by targeting calnexin for RACK1-mediated autophagic degradation.

Journal: Cell death & disease
Published: November 17, 2022

Targeting Oxidative Phosphorylation-Proteasome Activity in Extracellular Detached Cells Promotes Anoikis and Inhibits Metastasis.

Targeting Oxidative Phosphorylation-Proteasome Activity in Extracellular Detached Cells Promotes Anoikis and Inhibits Metastasis.

Journal: Life (Basel, Switzerland)
Published: October 30, 2021

Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy.

Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy.

Journal: Frontiers in immunology
Published: September 30, 2021

Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat.

Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat.

Journal: Frontiers in immunology
Published: April 28, 2021

Upregulation of V-ATPase by STAT3 Activation Promotes Anoikis Resistance and Tumor Metastasis.

Upregulation of V-ATPase by STAT3 Activation Promotes Anoikis Resistance and Tumor Metastasis.

Journal: Journal of Cancer
Published: January 26, 2021

Lipidomics data showing the effect of lipofermata on myeloid-derived suppressor cells in the spleens of tumor-bearing mice.

Lipidomics data showing the effect of lipofermata on myeloid-derived suppressor cells in the spleens of tumor-bearing mice.

Journal: Data in brief
Published: January 17, 2021

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming.

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming.

Journal: Frontiers in oncology
Published: November 06, 2020

Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.

Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.

Journal: Cellular immunology
Published: September 15, 2020

CD317 mediates immunocytolysis resistance by RICH2/cytoskeleton-dependent membrane protection.

CD317 mediates immunocytolysis resistance by RICH2/cytoskeleton-dependent membrane protection.

Journal: Molecular immunology
Published: August 25, 2020

Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy.

Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy.

Journal: Biochemical and biophysical research communications
Published: November 09, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026